Sarah Gilbert is a vaccinologist who is Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. Gilbert specializes in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011. On 30 December 2020, the Oxford–AstraZeneca COVID-19 vaccine she co-developed with the Oxford Vaccine Group was approved for use in the United Kingdom has been making and testing vaccines designed to induce T cell responses for over ten years, chiefly using antigens from malaria and influenza. Several of the vaccines developed in her laboratory have progressed into clinical trials.

Vaccines, COVID-19 Virus, Epidemics & Pandemics, Health, Emerging Tech, Innovation, Science, Research scientist, Researcher, Healthcare,